7Huang Yue，Breast Cancer Res Treat，1997年，42卷，7381页
8路建平，非放射性杂交技术，1996年，67页
9Carlos A. Encarnación,Daniel R. Ciocca,William L. McGuire,Gary M. Clark,Suzanne A. W. Fuqua,C. Kent Osborne. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen[J] 1993,Breast Cancer Research and Treatment(3):237～246
10Dr. F. Farinati,N. Maria,A. Fornasiero,M. Salvagnini,S. Fagiuoli,M. Chiaramonte,R. Naccarato. Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma[J] 1992,Digestive Diseases and Sciences(5):659～662
2Buzdar A, Hayes D, El-Khoudary A, et al. Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancer [J]. Breast Cancer Res Treat, 2002, 73(2) : 161-175.
3Fuchs WS, Leary WP, van der Meer MJ, et al. Pharmacokinetics and bioavailability of tamoxifen in postmenopausal healthy women[J ]. Arzneimittelforschung, 1996,46 ( 4 ) : 418-422.
4Buzdar AU, Hortobagyi GN, Frye D, etal. Bioequivalence of 20-rag once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens ~or breast cancer[J]. J Clin Oncol, 1994,12(1):50-54.
5Tukker JJ, Blankenstein MA, Nortier JW. Comparison of bioavailability in man of tamoxifen after oral and rectal administration[J]. J Pharm Pharmacol, 1986,38(12):888-892.
